ReShape Lifesciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Revenue	8.34	8.68	11.24	13.6	11.3	3.28	Upgrade
Revenue Growth (YoY)	-24.82%	-22.79%	-17.35%	20.36%	244.38%	-63.95%	Upgrade
Cost of Revenue	2.85	3.13	4.44	5.25	5.04	2.95	Upgrade
Gross Profit	5.49	5.55	6.8	8.35	6.26	0.33	Upgrade
Selling, General & Admin	14.36	17.87	31.34	33.21	15.22	16.67	Upgrade
Research & Development	2.35	2.32	2.54	2.37	3.5	6.89	Upgrade
Other Operating Expenses	0.74	0.74	19.27	30.65	0	0.06	Upgrade
Operating Expenses	17.45	20.93	53.15	66.23	18.72	23.62	Upgrade
Operating Income	-11.96	-15.38	-46.35	-57.88	-12.46	-23.29	Upgrade
Interest Expense / Income	-0.04	-0.03	0.11	0.83	2.05	0.39	Upgrade
Other Expense / Income	-1.06	-4.02	0.13	4.71	7.31	-	Upgrade
Pretax Income	-10.87	-11.34	-46.59	-63.42	-21.81	-23.68	Upgrade
Income Tax	0.05	0.05	-0.38	-0.27	-0.18	0	Upgrade
Net Income	-10.92	-11.39	-46.21	-63.15	-21.63	-23.68	Upgrade
Shares Outstanding (Basic)	23	6	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	23	6	0	0	0	0	Upgrade
Shares Change	1273.25%	1303.56%	94.21%	179.82%	148.88%	147.23%	Upgrade
EPS (Basic)	-0.65	-1.91	-108.90	-288.97	-277.00	-754.50	Upgrade
EPS (Diluted)	-0.65	-1.91	-108.90	-288.97	-277.00	-754.50	Upgrade
Free Cash Flow	-13.97	-16.97	-21.99	-15.73	-8.94	-23.06	Upgrade
Free Cash Flow Per Share	-0.60	-2.85	-51.83	-71.97	-114.48	-734.90	Upgrade
Gross Margin	65.85%	63.93%	60.52%	61.38%	55.42%	10.09%	Upgrade
Operating Margin	-143.50%	-177.26%	-412.38%	-425.60%	-110.25%	-709.88%	Upgrade
Profit Margin	-130.99%	-131.22%	-411.16%	-464.31%	-191.43%	-721.61%	Upgrade
Free Cash Flow Margin	-167.65%	-195.55%	-195.68%	-115.64%	-79.12%	-702.83%	Upgrade
EBITDA	-10.79	-11.21	-44.33	-60.62	-18.1	-22.4	Upgrade
EBITDA Margin	-129.44%	-129.14%	-394.38%	-445.71%	-160.15%	-682.63%	Upgrade
Depreciation & Amortization	0.11	0.15	2.15	1.97	1.67	0.89	Upgrade
EBIT	-10.9	-11.36	-46.48	-62.59	-19.76	-23.29	Upgrade
EBIT Margin	-130.79%	-130.92%	-413.53%	-460.21%	-174.90%	-709.88%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).